In stock · depth page
SS-31 — recent literature (RUO)
SS-31 / elamipretide literature, 2023–2026
SS-31 10 mg · literature note
For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide. This research material is not a licensed elamipretide product.
Clinical-development discussion in the literature stays context. It does not make this catalog vial a licensed elamipretide product.
How to read recent hits
Tung et al. (2025) reviews elamipretide structure and mechanism. Zheng et al. (2025) reports SS-31 mitochondrial targeting and ferroptosis readouts in hypoxia/reoxygenation cardiomyocytes. Zhao et al. (2004) and Birk et al. (2014) remain the mitochondria-targeted and cardiolipin anchors.
Review and cell-model papers stay literature context for research-use-only procurement.
Identity
Form
Lyophilized powder, sealed vial
Strength
10 mg lyophilized vial
Purity
≥99% HPLC
CAS
- Elamipretide / SS-31: 736992-21-5
PubMed
Selected literature
- PMID 15178689 (2004) Zhao et al., Journal of Biological Chemistry — mitochondria-targeted peptide antioxidants
- PMID 24134698 (2014) Birk, Szeto et al., British Journal of Pharmacology — cardiolipin and cytochrome c targeting
Recent literature (2023–2026)
- PMID 39940712 (2025) Tung et al., International Journal of Molecular Sciences — elamipretide structure and mechanism (review)
- PMID 39848110 (2025) Zheng et al., Biomedicine & Pharmacotherapy — SS-31 mitochondrial targeting and ferroptosis readouts in hypoxia/reoxygenation cardiomyocytes
Literature is scientific context only. A paper does not make a research vial into a licensed medicine.
Bench reconstitution
Dissolve the lyophilized SS-31 cake in bacteriostatic water to the mg/mL the protocol specifies. Run solvent down the glass wall. Swirl gently until the cake is gone. Do not vortex or shake. Record concentration, solvent lot, and time. This is a reconstitution volume, not a clinical dose.
Diluent page: bacteriostatic water.
Storage
Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.
Certificate of analysis
Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.
Lab FAQ
Do review or cardiomyocyte models authorize human-use claims?
No. Papers remain literature context. Write request@pharmapeptidesrx.com to add SS-31 to a research request. This page does not publish prices or banking details. Invoices go out from request@ only.
In this library
In stock · list price
Request from the catalog
Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.